173 related articles for article (PubMed ID: 21239898)
1. Differentiation and apoptosis in pilomatrixoma.
Ishige T; Kikuchi K; Miyazaki Y; Hara H; Yoshino A; Terui T; Katayama Y; Kusama K; Nemoto N
Am J Dermatopathol; 2011 Feb; 33(1):60-4. PubMed ID: 21239898
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
[TBL] [Abstract][Full Text] [Related]
3. Expression of hard alpha-keratins in pilomatrixoma, craniopharyngioma, and calcifying odontogenic cyst.
Kusama K; Katayama Y; Oba K; Ishige T; Kebusa Y; Okazawa J; Fukushima T; Yoshino A
Am J Clin Pathol; 2005 Mar; 123(3):376-81. PubMed ID: 15716233
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly differentiated cells in benign pilomatrixoma reflect the normal hair follicle: immunohistochemical analysis of Ca-binding S100A2, S100A3 and S100A6 proteins.
Kizawa K; Toyoda M; Ito M; Morohashi M
Br J Dermatol; 2005 Feb; 152(2):314-20. PubMed ID: 15727645
[TBL] [Abstract][Full Text] [Related]
5. Cell renewal, cell differentiation and programmed cell death (apoptosis) in pilomatrixoma.
Fayyazi A; Soruri A; Radzun HJ; Peters JH; Berger H
Br J Dermatol; 1997 Nov; 137(5):714-20. PubMed ID: 9415230
[TBL] [Abstract][Full Text] [Related]
6. Pilomatricoma can differentiate not only towards hair matrix and hair cortex, but also follicular infundibulum, outer root sheath and hair bulge.
Kurokawa I; Yamanaka K; Senba Y; Sugisaki H; Tsubura A; Kimura T; Mizutani H
Exp Dermatol; 2009 Aug; 18(8):734-7. PubMed ID: 19469893
[TBL] [Abstract][Full Text] [Related]
7. Expression of human hair keratin basic 1 in pilomatrixoma. A study of 128 cases.
Cribier B; Asch PH; Regnier C; Rio MC; Grosshans E
Br J Dermatol; 1999 Apr; 140(4):600-4. PubMed ID: 10233308
[TBL] [Abstract][Full Text] [Related]
8. Detection of apoptosis by in situ labeling in pilomatricoma.
Kishimoto S; Nagata M; Takenaka H; Yasuno H
Am J Dermatopathol; 1996 Aug; 18(4):339-43. PubMed ID: 8879295
[TBL] [Abstract][Full Text] [Related]
9. On the regulation of hair keratin expression: lessons from studies in pilomatricomas.
Cribier B; Peltre B; Grosshans E; Langbein L; Schweizer J
J Invest Dermatol; 2004 May; 122(5):1078-83. PubMed ID: 15140206
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
Demirkan NC; Bir F; Erdem O; Düzcan E
J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
[TBL] [Abstract][Full Text] [Related]
11. Comparative immunohistochemical analyses on the modes of cell death/keratinization in epidermal cyst, trichilemmal cyst, and pilomatricoma.
Nakamura T
Am J Dermatopathol; 2011 Feb; 33(1):78-83. PubMed ID: 21048491
[TBL] [Abstract][Full Text] [Related]
12. Cell adhesion protein expression in melanocytic matricoma.
Soler AP; Burchette JL; Bellet JS; Olson JA
J Cutan Pathol; 2007 Jun; 34(6):456-60. PubMed ID: 17518772
[TBL] [Abstract][Full Text] [Related]
13. Eyelid pilomatrixoma: a description of 16 cases and a review of the literature.
Levy J; Ilsar M; Deckel Y; Maly A; Anteby I; Pe'er J
Surv Ophthalmol; 2008; 53(5):526-35. PubMed ID: 18929763
[TBL] [Abstract][Full Text] [Related]
14. beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst.
Hassanein AM; Glanz SM; Kessler HP; Eskin TA; Liu C
Am J Clin Pathol; 2003 Nov; 120(5):732-6. PubMed ID: 14608900
[TBL] [Abstract][Full Text] [Related]
15. Ghost cells in pilomatrixoma, craniopharyngioma, and calcifying cystic odontogenic tumor: histological, immunohistochemical, and ultrastructural study.
Rumayor A; Carlos R; Kirsch HM; de Andrade BA; Romañach MJ; de Almeida OP
J Oral Pathol Med; 2015 Apr; 44(4):284-90. PubMed ID: 25047924
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Localization of Phosphorylated and Unphosphorylated Form of β-catenin With Regard to Shadow Cell and Squamous Differentiation in Cutaneous Pilomatricoma.
Nakamura T; Fujiwara M
Am J Dermatopathol; 2020 Nov; 42(11):835-841. PubMed ID: 32310857
[TBL] [Abstract][Full Text] [Related]
17. Anetodermic pilomatricoma.
de Souza EM; Ayres Vallarelli AF; Cintra ML; Vetter-Kauczok CS; Brocker EB
J Cutan Pathol; 2009 Jan; 36(1):67-70. PubMed ID: 18715255
[TBL] [Abstract][Full Text] [Related]
18. Pilomatricoma: a tumor with hidden depths.
Simi CM; Rajalakshmi T; Correa M
Indian J Dermatol Venereol Leprol; 2010; 76(5):543-6. PubMed ID: 20826995
[TBL] [Abstract][Full Text] [Related]
19. A reappraisal on the modes of cell death in pilomatricoma.
Nakamura T
J Cutan Pathol; 1999 Mar; 26(3):125-9. PubMed ID: 10235377
[TBL] [Abstract][Full Text] [Related]
20. A common human skin tumour is caused by activating mutations in beta-catenin.
Chan EF; Gat U; McNiff JM; Fuchs E
Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
